| Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive studied in …STUDIED_INderived122 of 122show fewer |
|---|
| → studied in | NCT03560752Phase 1 · active not recruiting CMV-MVA Triplex Vaccination of Stem Cell Donors in Preventing CMV Viremia in Participants With Allogeneic Transplant · condition mapped ALIAS · 122 trials mapped (31 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05007873Phase 2 · active not recruiting ASTX727 and Dasatinib for the Treatment of Newly Diagnosed Philadelphia Chromosome or BCR-ABL Positive Chronic Myeloid Leukemia in Chronic Phase · condition mapped ALIAS · 122 trials mapped (31 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01746836Phase 2 · recruiting Ponatinib Hydrochloride as Second Line Therapy in Treating Patients With Chronic Myeloid Leukemia in Chronic Phase Resistant or Intolerant to Imatinib Mesylate, Dasatinib, or Nilotinib · condition mapped ALIAS · 122 trials mapped (31 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03516279Phase 2 · active not recruiting Pembrolizumab and Dasatinib, Imatinib Mesylate, or Nilotinib in Treating Patients With Chronic Myeloid Leukemia and Persistently Detectable Minimal Residual Disease · condition mapped ALIAS · 122 trials mapped (31 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06423911Phase 3 · recruiting Study of Olverembatinib (HQP1351) in Patients With CML-CP · condition mapped ALIAS · 122 trials mapped (31 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02689440Phase 2 · active not recruiting Dasatinib and Venetoclax in Treating Patients With Philadelphia Chromosome Positive or BCR-ABL1 Positive Early Chronic Phase Chronic Myelogenous Leukemia · condition mapped ALIAS · 122 trials mapped (31 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03459534Phase 3 · recruiting A Phase 3 Study for the Efficacy and Safety of Radotinib in CP-CML Patients With Failure or Intolerance to Previous TKIs · condition mapped ALIAS · 122 trials mapped (31 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03722420Phase 3 · active not recruiting Randomized Evaluation of Radotinib Versus Imatinib in Phase III Study for Efficacy With Chinese Patients (RERISE China) · condition mapped ALIAS · 122 trials mapped (31 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04838041Phase 2 · recruiting Protocol Number: HJKC3-0003. Treatment Free Remission After Asciminib Based Therapy in Chronic Phase Chronic Myeloid Leukemia (CP-CML) Patients Who Relapsed After a Prior Attempt at TKI Discontinuation · condition mapped ALIAS · 122 trials mapped (31 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02727803Phase 2 · recruiting Personalized NK Cell Therapy in CBT · condition mapped ALIAS · 122 trials mapped (31 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02506933Phase 2 · active not recruiting Multi-antigen CMV-MVA Triplex Vaccine in Reducing CMV Complications in Patients Previously Infected With CMV and Undergoing Donor Hematopoietic Cell Transplant · condition mapped ALIAS · 122 trials mapped (31 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07020533Phase 1 · recruiting A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant · condition mapped ONTOLOGY_EXACT · 122 trials mapped (31 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03934372Phase 1/Phase 2 · recruiting Safety and Efficacy of Ponatinib for Treatment of Pediatric Recurrent or Refractory Leukemias, Lymphomas or Solid Tumors · condition mapped ALIAS · 122 trials mapped (31 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05143840Phase 2 · active not recruiting Asciminib as Initial Therapy for Patients With Chronic Myeloid Leukemia in Chronic Phase · condition mapped ALIAS · 122 trials mapped (31 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03817398Phase 2 · active not recruiting Stopping Tyrosine Kinase Inhibitors in Affecting Treatment-Free Remission in Patients With Chronic Phase Chronic Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 122 trials mapped (31 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03610971Phase 2 · active not recruiting Treatment Free Remission After Combination Therapy With Ruxolitinib Plus Tyrosine Kinase Inhibitors · condition mapped ALIAS · 122 trials mapped (31 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06368414Phase 2 · recruiting A Study of Treatment-free Remission in Chronic Phase Chronic Myeloid Leukemia · condition mapped ALIAS · 122 trials mapped (31 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05304377Phase 1 · recruiting A Phase 1a/1b Study of ELVN-001 for the Treatment Chronic Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 122 trials mapped (31 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06229860recruiting Impact of Personality on Adherence to Tyrosine Kinase Inhibitor Therapy in Pts w/Chronic Myeloid Leukemia · condition mapped ALIAS · 122 trials mapped (31 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01199562active not recruiting Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant · condition mapped ALIAS · 122 trials mapped (31 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00254423Phase 2 · completed Dasatinib in Treating Patients With Early Chronic Phase Chronic Myelogenous Leukemia · condition mapped ALIAS · 122 trials mapped (31 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06163430Phase 1/Phase 2 · recruiting A Phase 1/2 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of TERN-701 in Participants With Chronic Myeloid Leukemia (CARDINAL) · condition mapped ALIAS · 122 trials mapped (31 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03654768Phase 2 · active not recruiting Testing the Addition of Ruxolitinib to the Usual Treatment (Tyrosine Kinase Inhibitors) for Chronic Myeloid Leukemia · condition mapped ALIAS · 122 trials mapped (31 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04060277Phase 2 · active not recruiting Triplex Vaccine in Preventing CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplantation · condition mapped ALIAS · 122 trials mapped (31 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04258943Phase 1/Phase 2 · active not recruiting Bosutinib in Pediatric Patients With Newly Diagnosed Chronic Phase or Resistant/Intolerant Ph + Chronic Myeloid Leukemia · condition mapped ALIAS · 122 trials mapped (31 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06409936Phase 2 · recruiting PEARL Study: PotEntial of Asciminib in the eaRly Treatment of CML · condition mapped ALIAS · 122 trials mapped (31 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03333486Phase 2 · terminated Fludarabine Phosphate, Cyclophosphamide, Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Blood Cancer · condition mapped ALIAS · 122 trials mapped (31 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06787144Phase 1 · recruiting ELVN-001 for the Treatment of Chronic Myeloid Leukemia With and Without T315I Mutation in Japanese Participants · condition mapped ALIAS · 122 trials mapped (31 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06119269recruiting Ponatinib in Chronic Myeloid Leukemia Patients in Chronic Phase · condition mapped ALIAS · 122 trials mapped (31 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04694820NA · completed A Mobile Intervention (txt4TKI) for the Improvement of Tyrosine Kinase Inhibitor Management in Patients With Chronic Myeloid Leukemia · condition mapped ALIAS · 122 trials mapped (31 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00719888Phase 2 · completed Umbilical Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With Hematologic Disease · condition mapped ALIAS · 122 trials mapped (31 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02396134Phase 2 · completed Vaccine Therapy in Reducing the Frequency of Cytomegalovirus Events in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant · condition mapped ALIAS · 122 trials mapped (31 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04126681Phase 2 · completed A Pivotal Study of HQP1351 in Patients With Chronic Myeloid Leukemia in Chronic Phase · condition mapped ALIAS · 122 trials mapped (31 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04160546Phase 2 · active not recruiting Study to Evaluate the Reinduction and Second Stop of TKI with Ponatinib in CML in Molecular Response (ResToP) · condition mapped ALIAS · 122 trials mapped (31 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04147533Phase 2 · active not recruiting Efficacy and Safety of TKIs' Withdrawal After a Two-step Dose Reduction in Patients with Chronic Myeloid Leukemia · condition mapped ALIAS · 122 trials mapped (31 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06516029completed Real-World Evaluation of Patient Characteristics and Treatment Patterns Among Patients With CML-CP Treated With Asciminib · condition mapped ALIAS · 122 trials mapped (31 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04666025completed SARS-CoV-2 Donor-Recipient Immunity Transfer · condition mapped ALIAS · 122 trials mapped (31 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01588015Phase 1 · completed Vaccine Therapy in Preventing Cytomegalovirus Infection in Patients With Hematological Malignancies Undergoing Donor Stem Cell Transplant · condition mapped ALIAS · 122 trials mapped (31 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04793399Phase 1/Phase 2 · terminated Safety and Efficacy Evaluation of Bosutinib Plus Atezolizumab in Newly Diagnosed Chronic Leukemia Adult Patients · condition mapped ALIAS · 122 trials mapped (31 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03878524Phase 1 · terminated Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME Trial · condition mapped ALIAS · 122 trials mapped (31 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06233890unknown The Analysis of Fatigue on Tyrosine Kinase Inhibitor Therapy in Chronic Myeloid Leukaemia · condition mapped ALIAS · 122 trials mapped (31 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06121765unknown Metabolic Alternation and Clinicohematological Characteristic in Chronic Phase CML in Patient Treated With TKI · condition mapped ALIAS · 122 trials mapped (31 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01428635Phase 2/Phase 3 · completed Eltrombopag Olamine in Treating Thrombocytopenia in Patients With Chronic Myeloid Leukemia or Myelofibrosis Receiving Tyrosine Kinase Therapy · condition mapped ALIAS · 122 trials mapped (31 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01593254Phase 2 · completed Study of Dasatinib vs Imatinib in Patients With Chronic Myeloid Leukemia (CML) Who Did Not Have Favorable Response to Imatinib · condition mapped ALIAS · 122 trials mapped (31 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03933852unknown Observational Study on Chronic Myeloid Leukemia Patients in Any Phase Treated With Ponatinib (Iclusig®) at Any Dose · condition mapped ALIAS · 122 trials mapped (31 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03883087Phase 2 · unknown A Pivotal Study of HQP1351 in Patients of Chronic Myeloid Leukemia in Chronic Phase With T315I Mutation · condition mapped ALIAS · 122 trials mapped (31 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00796068Phase 2 · completed Treosulfan, Fludarabine Phosphate, and Total-Body Irradiation in Treating Patients With Hematological Cancer Who Are Undergoing Umbilical Cord Blood Transplant · condition mapped ALIAS · 122 trials mapped (31 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02960646Phase 1 · completed Engineered Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies · condition mapped ALIAS · 122 trials mapped (31 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04605211NA · completed A Distress Reduction Intervention for Patients With BCR-ABL-Negative MPNs or CML on Tyrosine Kinase Inhibitors · condition mapped ALIAS · 122 trials mapped (31 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05367700Phase 1 · recruiting A Study of HS-10382 in Patients With Chronic Myeloid Leukemia. · condition mapped ALIAS · 122 trials mapped (31 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03885830completed Precision Dosing of Tyrosine Kinase Inhibitors in CML Patients · condition mapped ALIAS · 122 trials mapped (31 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03045120completed Determining Change in Cardiovascular and Metabolic Risks in Patients With Chronic Phase Chronic Myeloid Leukemia Receiving BCR-ABL Tyrosine Kinase Inhibitor First-Line Therapy in the United States · condition mapped ALIAS · 122 trials mapped (31 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05638763Phase 2 · unknown Cytochrome P450 Inhibition to Decrease Dosage of Dasatinib for Chronic Myelogenous Leukemia · condition mapped ALIAS · 122 trials mapped (31 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01850004Phase 2 · completed Open-Label Study Evaluating Dasatinib Therapy Discontinuation in Patients With Chronic Phase Chronic Myeloid Leukemia With Stable Complete Molecular Response · condition mapped ALIAS · 122 trials mapped (31 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05543161unknown "Peripheral Blood Dipeptidylpeptidase IV (CD26) Positive Leukemic Stem Cells in Chronic Myeloid Leukemia as a Diagnostic Marker" · condition mapped ALIAS · 122 trials mapped (31 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05311943Phase 3 · unknown Treatment With Olverembatinib in CML-CP Patients Who Failed to at Least Two Previously Administered Second-generation TKIs. · condition mapped ALIAS · 122 trials mapped (31 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04006847Phase 1/Phase 2 · terminated Omega -3 Fatty Acid in Combination With Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia · condition mapped ALIAS · 122 trials mapped (31 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05367765Phase 4 · not yet recruiting A Real World Study of the Efficacy and Safety of Flumatinib Versus Imatinib in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase · condition mapped ALIAS · 122 trials mapped (31 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05353205Phase 4 · unknown A Study of the Efficacy and Safety of Flumatinib in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase. · condition mapped ALIAS · 122 trials mapped (31 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00450450Phase 3 · completed Donor Bone Marrow Transplant With or Without G-CSF in Treating Young Patients With Hematologic Cancer or Other Diseases · condition mapped ALIAS · 122 trials mapped (31 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03942094Phase 3 · unknown Nilotinib for First-line Newly Diagnosed CML-CP Patients · condition mapped ALIAS · 122 trials mapped (31 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04677439Phase 4 · unknown Flumatinib in CML-CP Patients With Ph+ Post Imatinib Failure · condition mapped ALIAS · 122 trials mapped (31 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02627677Phase 3 · terminated A Study Comparing Ponatinib and Nilotinib in Participants With Chronic Myeloid Leukemia · condition mapped ALIAS · 122 trials mapped (31 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03647215completed CALLS: CML and Ph+ALL Low Level Mutation Prevalence Survey · condition mapped ALIAS · 122 trials mapped (31 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03602898Phase 2 · withdrawn Comparing ATG or Post-Transplant Cyclophosphamide to Calcineurin Inhibitor-Methotrexate as GVHD Prophylaxis After Myeloablative Unrelated Donor Peripheral Blood Stem Cell Transplantation · condition mapped ALIAS · 122 trials mapped (31 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04883125Phase 2 · completed Value of Using Pioglitazone in Chronic Myeloid Leukemia Treatment · condition mapped ALIAS · 122 trials mapped (31 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00489203Phase 2 · completed Beclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer · condition mapped ALIAS · 122 trials mapped (31 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01702064Phase 1 · completed Ruxolitinib in Combination With Nilotinib in Chronic Myeloid Leukemia (CML) Patients · condition mapped ALIAS · 122 trials mapped (31 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01914484Phase 1/Phase 2 · completed Phase I/II Study of Nilotinib/Ruxolitinb Therapy for TKI Resistant Ph-Leukemia · condition mapped ALIAS · 122 trials mapped (31 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02906696Phase 2 · terminated Bosutinib in Treating Patients With Chronic Myeloid Leukemia in Chronic Phase After Frontline TKI Failure · condition mapped ALIAS · 122 trials mapped (31 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01619761Phase 1 · unknown NK Cells in Cord Blood Transplantation · condition mapped ALIAS · 122 trials mapped (31 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00040846Phase 2 · completed Alemtuzumab, Fludarabine Phosphate, and Low-Dose Total Body Irradiation Before Donor Stem Cell Transplantation in Treating Patients With Hematological Malignancies · condition mapped ALIAS · 122 trials mapped (31 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00089011Phase 2 · completed Tacrolimus and Mycophenolate Mofetil in Preventing Graft-Versus-Host Disease in Patients Who Have Undergone Total-Body Irradiation With or Without Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant for Hematologic Cancer · condition mapped ALIAS · 122 trials mapped (31 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03882281Phase 1 · completed Pharmacokinetics Profiles of HQP1351 Under Fasting and High-fat Meals in Patients With Chronic Myeloid Leukemia · condition mapped ALIAS · 122 trials mapped (31 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00078858Phase 1/Phase 2 · completed Mycophenolate Mofetil and Cyclosporine in Reducing Graft-Versus-Host Disease in Patients With Hematologic Malignancies or Metastatic Kidney Cancer Undergoing Donor Stem Cell Transplant · condition mapped ALIAS · 122 trials mapped (31 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00723099Phase 2 · completed Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer · condition mapped ALIAS · 122 trials mapped (31 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01251575Phase 2 · completed Sirolimus, Cyclosporine, and Mycophenolate Mofetil in Preventing Graft-versus-Host Disease in Treating Patients With Blood Cancer Undergoing Donor Peripheral Blood Stem Cell Transplant · condition mapped ALIAS · 122 trials mapped (31 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00856388NA · completed Fludarabine Phosphate, Melphalan, Total-Body Irradiation, Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Bone Marrow Failure Disorders · condition mapped ALIAS · 122 trials mapped (31 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03907670unknown Chronic Myloid Leukemic Patients Treated With Tyrosine Kinase Inhibitor · condition mapped ALIAS · 122 trials mapped (31 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01529827Phase 2 · completed Fludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies · condition mapped ALIAS · 122 trials mapped (31 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00005799NA · completed Fludarabine Phosphate, Low-Dose Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer · condition mapped ALIAS · 122 trials mapped (31 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01839916Phase 2 · completed Donor T Cells After Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies · condition mapped ALIAS · 122 trials mapped (31 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01159067Phase 2 · terminated Deferasirox for Treating Patients Who Have Undergone Allogeneic Stem Cell Transplant and Have Iron Overload · condition mapped ALIAS · 122 trials mapped (31 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01175785Phase 2 · completed Infusion of Off-the-Shelf Expanded Cord Blood Cells to Augment Cord Blood Transplant in Patients With Hematologic Malignancies · condition mapped ALIAS · 122 trials mapped (31 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01093586Phase 2 · completed Donor Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies · condition mapped ALIAS · 122 trials mapped (31 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01933906Phase 1 · completed Addition of P1101 to Imatinib Treatment in Patients With Chronic Phase Chronic Myeloid Leukaemia Not Achieving a Complete Molecular Response · condition mapped ALIAS · 122 trials mapped (31 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03438344Phase 2 · withdrawn Multi-antigen CMV-Modified Vaccinia Ankara Vaccine in Reducing CMV Related Complications in Patients With Blood Cancer Undergoing Donor Stem Cell Transplant · condition mapped ALIAS · 122 trials mapped (31 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02728700Phase 1 · terminated Sirolimus and Mycophenolate Mofetil in Preventing GVHD in Patients With Hematologic Malignancies Undergoing HSCT · condition mapped ALIAS · 122 trials mapped (31 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01490775NA · terminated Pilot Study to Assess Telemonitoring of Gleevec (Imatinib Mesylate) or Tasigna (Niltinib) Therapy · condition mapped ALIAS · 122 trials mapped (31 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01789255Phase 2 · completed Vorinostat, Tacrolimus, and Methotrexate in Preventing GVHD After Stem Cell Transplant in Patients With Hematological Malignancies · condition mapped ALIAS · 122 trials mapped (31 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01053494NA · completed Massage Therapy Given by Caregiver in Treating Quality of Life of Young Patients Undergoing Treatment for Cancer · condition mapped ALIAS · 122 trials mapped (31 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03332511Phase 4 · completed Efficacy and Safety of Nilotinib in CML-CP · condition mapped ALIAS · 122 trials mapped (31 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00309907Phase 2 · completed Etanercept in Treating Young Patients With Idiopathic Pneumonia Syndrome After Undergoing a Donor Stem Cell Transplant · condition mapped ALIAS · 122 trials mapped (31 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00702403Phase 1/Phase 2 · completed Nilotinib and Imatinib Mesylate After Donor Stem Cell Transplant in Treating Patients With ALL or CML · condition mapped ALIAS · 122 trials mapped (31 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01076270NA · terminated Plerixafor and Filgrastim For Mobilization of Donor Peripheral Blood Stem Cells Before A Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies · condition mapped ALIAS · 122 trials mapped (31 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00118352Phase 2 · completed Alemtuzumab, Fludarabine Phosphate, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer · condition mapped ALIAS · 122 trials mapped (31 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00112593NA · completed Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without Cancer · condition mapped ALIAS · 122 trials mapped (31 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00795769Phase 2 · completed Ondansetron in Preventing Nausea and Vomiting in Patients Undergoing Stem Cell Transplant · condition mapped ALIAS · 122 trials mapped (31 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01427881Phase 2 · completed Cyclophosphamide for Prevention of Graft-Versus-Host Disease After Allogeneic Peripheral Blood Stem Cell Transplantation in Patients With Hematological Malignancies · condition mapped ALIAS · 122 trials mapped (31 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00075478Phase 3 · completed Total-Body Irradiation With or Without Fludarabine Phosphate Followed By Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer · condition mapped ALIAS · 122 trials mapped (31 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00408681NA · completed Lithium Carbonate in Treating Patients With Acute Intestinal Graft-Versus-Host-Disease (GVHD) After Donor Stem Cell Transplant · condition mapped ALIAS · 122 trials mapped (31 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02977312completed Study of Cemivil® (Imatinib) in Chronic Myeloid Leukemia Patients in Jordan · condition mapped ALIAS · 122 trials mapped (31 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01660906Phase 4 · completed Phase IV, Open-label, Multicenter Study of Dasatinib in Chronic-Phase Chronic Myeloid Leukemia (CP-CML) Patients With Chronic, Low-grade Non-Hematologic Toxicity to Imatinib · condition mapped ALIAS · 122 trials mapped (31 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02949570Phase 2 · unknown Study to Assess Efficacy and Safety of Inecalcitol in Imatinib-Treated Residual Chronic Myeloid Leukaemia: INIM Study · condition mapped ALIAS · 122 trials mapped (31 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01056614Phase 2 · completed Fludarabine Phosphate, Busulfan, and Anti-Thymocyte Globulin Followed By Donor Peripheral Blood Stem Cell Transplant, Tacrolimus, and Methotrexate in Treating Patients With Myeloid Malignancies · condition mapped ALIAS · 122 trials mapped (31 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00343798Phase 1 · completed A Pilot Study to Evaluate the Co-Infusion of Ex Vivo Expanded Cord Blood Cells With an Unmanipulated Cord Blood Unit in Patients Undergoing Cord Blood Transplant for Hematologic Malignancies · condition mapped ALIAS · 122 trials mapped (31 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00387426Phase 2 · terminated Sunitinib in Treating Patients With Idiopathic Myelofibrosis · condition mapped ALIAS · 122 trials mapped (31 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01231919Phase 1 · completed MK2206 in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Leukemia · condition mapped ALIAS · 122 trials mapped (31 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01233921NA · completed Palifermin in Preventing Chronic Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer · condition mapped ALIAS · 122 trials mapped (31 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01426334Phase 1 · terminated Dasatinib and Cyclosporine in Treating Patients With Chronic Myelogenous Leukemia Refractory or Intolerant to Imatinib Mesylate · condition mapped ALIAS · 122 trials mapped (31 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00890747Phase 1 · completed Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy · condition mapped ALIAS · 122 trials mapped (31 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003694Phase 2 · completed Homoharringtonine Plus Low-Dose Cytarabine in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia in Chronic Phase · condition mapped ALIAS · 122 trials mapped (31 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00049192Phase 2 · completed Oblimersen and Imatinib Mesylate in Treating Patients With Chronic Myelogenous Leukemia · condition mapped ALIAS · 122 trials mapped (31 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00025415Phase 1 · completed Imatinib Mesylate in Treating Patients With Advanced Cancer and Liver Dysfunction · condition mapped ALIAS · 122 trials mapped (31 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00006364Phase 2 · completed Homoharringtonine in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia · condition mapped ALIAS · 122 trials mapped (31 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00030394Phase 2 · completed Imatinib Mesylate in Treating Patients With Chronic Myelogenous Leukemia · condition mapped ALIAS · 122 trials mapped (31 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00101088Phase 1 · terminated Temsirolimus and Imatinib Mesylate in Treating Patients With Chronic Myelogenous Leukemia · condition mapped ALIAS · 122 trials mapped (31 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00012376Phase 1 · completed Chemotherapy Plus Sargramostim in Treating Patients With Refractory Myeloid Cancer · condition mapped ALIAS · 122 trials mapped (31 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00004918Phase 1/Phase 2 · completed Vaccine Therapy Plus Immune Adjuvant in Treating Patients With Chronic Myeloid Leukemia, Acute Myeloid Leukemia, or Myelodysplastic Syndrome · condition mapped ALIAS · 122 trials mapped (31 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01558778NA · withdrawn Mechanical Stimulation in Preventing Bone Density Loss in Patients Undergoing Donor Stem Cell Transplant · condition mapped ALIAS · 122 trials mapped (31 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00799461Phase 3 · completed Internet-Based Program With or Without Telephone-Based Problem-Solving Training in Helping Long-Term Survivors of Hematopoietic Stem Cell Transplant Cope With Late Complications · condition mapped ALIAS · 122 trials mapped (31 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01177371Phase 2 · completed High-Dose Busulfan and High-Dose Cyclophosphamide Followed By Donor Bone Marrow Transplant in Treating Patients With Leukemia, Myelodysplastic Syndrome, Multiple Myeloma, or Recurrent Hodgkin or Non-Hodgkin Lymphoma · condition mapped ALIAS · 122 trials mapped (31 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |